Aromics Biotech (@aromicsbiotech) header
Aromics Biotech (@aromicsbiotech) profile picture

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target human diseases.

Barcelona
Joined May 2010
Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)Photo by Aromics Biotech (@aromicsbiotech)
Replying to @aromicsbiotech
@aromicsbiotech is developing an innovative treatment for mesothelioma, an incurable cancer related to #asbestos exposure. Check it out the advances at @bermesproject, an #H2020 #smeinstrument project funded by @EU_Commission @CORDIS_EU @ComisionEuropea @ComissioEuropea #EWAC2020
2
6
840,000 deaths a year linked to psychosocial risks at work. Listen to the new ILO podcast and hear why improving the way work is designed, organized and managed is essential for safer and healthier workplaces. 🎧 ow.ly/tV1h50YQUzN
10
33
2
63
5,165
Víctimas y afectados por el #amianto piden un compromiso real para aplicar la #ley #erradicación del #amianto. Acto reconocimiento en el parlament de Catalunya @parlament parlament.cat/web/galeria-im… a través de @parlament_cat
1
17
Aromics Biotech retweeted
📍15 abril 2026 . 17h. JORNADA DE PRESENTACIÓN OFICIAL DE LA SOCSA. Deseamos que sea un espacio de encuentro entorno la salud y la #medicinambiental en los sistemas sanitarios actuales. Presencial. Gratuito con inscripción previa. Os esperamos! socsa.cat/actividad/id/29493…
1
2
50
Aromics Biotech retweeted
Today we announced positive results from the ongoing Phase 1/2 ARIA clinical trial evaluating REM-422, a first-in-class MYB mRNA degrader, in patients with R/M ACC The data will be featured in an oral presentation at #ASCO2026. Read the press release: bit.ly/4dpGN6Y
2
4
390
Aromics Biotech retweeted
At the International Myotonic Dystrophy Consortium this week, Domi Stickens, PhD, Chief Scientific Officer, presents a poster on our RNA-targeted small-molecule therapeutics and the first oral therapy in development for myotonic dystrophy type 1 #DM1. #IDMC15 #MyotonicDystrophy
3
3
272
player.watchity.com/?wctWatc…. At the #Parliament of #CATALONIA , a historic institutional act of recognition and redress for asbestos victims. A day for justice, memory and prevention. @bermesproject @ADAO_Spanish @CORDIS_EU @ComisionEuropea @CDTI_innovacion @P_Recuperacion
1
10
Aromics Biotech retweeted
1
4
2
319
Aromics Biotech retweeted
Hoy participamos en la 13ª Conferencia del Programa Marco del CDTI, “Entre dos Programas, Horizonte Europa”, un punto de encuentro clave para alinear nuestra estrategia en terapias oncológicas innovadoras con las próximas oportunidades europeas de I+D
1
1
17